Eric Wombwell – COVID-19 and Influenza Vaccine Updates for the Geriatric Patient: Clinical Considerations to Optimize Protection

*** Proof of Product ***

---

Exploring the Essential Features of “Eric Wombwell – COVID-19 and Influenza Vaccine Updates for the Geriatric Patient: Clinical Considerations to Optimize Protection”

Speaker: Eric Wombwell, PharmD, BCIDP

Duration: 1 Hour 04 Minutes

Format: Audio and Video

Copyright: Oct 26, 2021  

Media Type: Digital Seminar

Description

It’s challenging to stay current on the evolving status of COVID-19 and influenza, with mutations in both viruses impacting the efficacy of vaccinations. This session will deliver an evidence-based assessment of COVID-19 and Influenza vaccines in the geriatric population. Eric Wombwell, PharmD, BCIDP, a board-certified infectious diseases pharmacist, will deliver the very latest updates to guide optimal administration of vaccines for COVID-19 and influenza. Practitioners will conclude the training with confidence in their decision-making.

Speaker

Dr. Eric Wombwell is a board-certified infectious diseases pharmacist and clinical associate professor for the Department of Pharmacy Practice and Administration at the University of Missouri – Kansas City, School of Pharmacy. Eric completed his PharmD degree at the University of Missouri Kansas City, followed by an ASHP accredited pharmacy practice residency at the Kansas City VA Medical Center. Following residency, he accepted a full-time non-tenured clinical faculty position at the University of Missouri – Kansas City, School of Pharmacy. His teaching responsibilities include infectious diseases topics throughout the curriculum. Eric also has a clinical appointment at Centerpoint Medical Center rounding with the infectious diseases consult team and supporting antimicrobial stewardship efforts at the facility.

Eric is regularly published in pharmacy and infectious diseases research and is frequently invited to deliver continuing education presentations locally and nationally to various health-professional audiences. He is recognized for excellence in teaching through various awards, including the “Missouri Pharmacist Association – UMKC Faculty Member of the Year”, and the “University of Missouri – Kansas City Provost’s Award for Excellence in Teaching”.

Speaker Disclosures:
Financial: Eric Wombwell has an employment relationship with the University of Missouri. He receives a speaking honorarium, recording royalties, and a consulting fee from PESI, Inc. He has no relevant financial relationships with ineligible organizations.
Non-financial: Eric Wombwell is a member of the Society of Infectious Diseases Pharmacists, the Missouri Pharmacists Association, American Association of Colleges of Pharmacy, Infectious Diseases Society of America, and Centerpoint Medical Center.

Objectives

1. Analyze the efficacy of currently available COVID-19 vaccines for evolving variants. 
2. Differentiate efficacy amongst influenza vaccines in the geriatric population. 
3. Choose the influenza vaccine most effective for a geriatric patient.

Outline

COVID-19

• Current prevalence of variants – what is dominating, where are trends moving 
• Efficacy of available COVID-19 vaccines for currently circulating variants 
• Current safety data for available COVID-19 vaccines 
• Evidence for new or altered COVID-19 vaccines for currently circulating and evolving variants 

Influenza

• Current dominant strains compared to strains in vaccine 
• Efficacy comparison of recombinant, adjuvanted, and standard quadrivalent influenza vaccines 
• Optimal timing of influenza vaccine 

Target Audience

• Nurses
• Nurse Practitioners
• Clinical Nurse Specialists
• Physician Assistants
• Physicians
• Physical Therapists
• Physical Therapist Assistants
• Occupational Therapists
• Occupational Therapy Assistants
• Speech Language Pathologists
• Social Workers
• Nursing Home Administrators

Please see the full list of alternative group-buy courses available here: https://lunacourse.com/shop/